Bellevue Dermatology Clinic

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Psoriasis3 trials
• Obesity2 trials
• Psoriatic arthritis1 trial

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• University of Pennsylvania1 trial

Running trials

• Recruiting

  A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

  NCT06857942· Phase 4· Eli Lilly and Company· Source

  Contact: Clive Liu (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity1 recruiting
• Psoriasis1 recruiting

Closed trials

• Completed

  Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight

  NCT06588283· Phase 3· Eli Lilly and Company· Source

• Completed

  Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis

  NCT05908240· University of Pennsylvania· Source